Highlights and Quick Summary
- Annual ROA for 2021 was -39.89% (a -44.36% decrease from previous year)
- Annual ROA for 2020 was -71.69% (a 6.03% increase from previous year)
- Annual ROA for 2019 was -67.61% (a 8.54% increase from previous year)
- Twelve month ROA ending September 30, 2022 was -46.91% (a -11.86% decrease compared to previous quarter)
- Twelve month trailing ROA increased by 17.6% year-over-year
Trailing ROA for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -46.91% | -53.22% | -47.77% | -39.89% |
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROA of BioCryst Pharmaceuticals, Inc.
Most recent ROAof BCRX including historical data for past 10 years.Interactive Chart of ROA of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. ROA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | -39.89% |
| 2020 | – | – | – | – | -71.69% |
| 2019 | – | – | – | – | -67.61% |
| 2018 | – | – | – | – | -62.29% |
| 2017 | – | – | – | – | -49.07% |
| 2016 | – | – | – | – | -51.97% |
| 2015 | – | – | – | – | -33.19% |
| 2014 | – | – | – | – | -48.66% |
| 2013 | – | – | – | – | -56.64% |
| 2012 | – | – | – | – | -55.97% |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology